BIOCONNSEBiocon Limited· PharmaceuticalsLowNeutral
Announced Fri, 8 May · 21:38 IST

Biocon Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.6%1-day move
₹378.70
prior close
₹380.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-1.0-0.3+0.3+6.6+9.9+10.4+13.7+12.8+14.6+10.0+10.0+9.0
Up moveDown movePending
AI summary

Biocon Limited has filed a routine regulatory disclosure informing exchanges that audio and video recordings of their Q4 FY26 Earnings Call (conducted on May 08, 2026) are now available on the company's website. This filing complies with Regulation 30 of SEBI LODR requirements. The recording link points to the investor relations section at www.biocon.com. No new financial figures, guidance, or material information is provided in this announcement itself. The earnings call would have covered quarterly performance discussions, but this filing only shares access to that recording.

Likely market impact

This is a standard administrative disclosure with no immediate impact on shareholders or stock price. The actual earnings call content may contain relevant information, but this filing itself does not disclose any new financial data, guidance updates, or material developments.